A Look at Immunovant's Upcoming Earnings Report

Immunovant (NASDAQ:IMVT) will release its quarterly earnings report on Friday, 2026-02-06. Here's a brief overview for investors ahead of the announcement.

Analysts anticipate Immunovant to report an earnings per share (EPS) of $-0.71.

Immunovant bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Historical Earnings Performance

The company's EPS missed by $0.01 in the last quarter, leading to a 2.05% drop in the share price on the following day.

Here's a look at Immunovant's past performance and the resulting price change:

Quarter	Q2 2026	Q1 2026	Q4 2025	Q3 2025
EPS Estimate	-0.72	-0.68	-0.72	-0.76
EPS Actual	-0.73	-0.71	-0.64	-0.76
Price Change %	-2.00	3.00	0.00	0.00

Market Performance of Immunovant's Stock

Shares of Immunovant were trading at $25.15 as of February 04. Over the last 52-week period, shares are up 24.96%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.

To track all earnings releases for Immunovant visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.